Australian researchers uncover cause of treatment resistance in common breast cancer
Scientists in Sydney have identified how inactivation of a stress-response pathway enables estrogen receptor-positive breast cancer cells to resist treatment, a finding that could help doctors predict therapy outcomes and tailor treatment.